Immunotherapy | Tumor

CURE’s immunotherapy page features the latest cancer news and updates on immunotherapy Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in immunotherapy.

Promise in Pancreatic Cancer

February 10th 2017, 11:59pm

Video

Keytruda Benefits Rare Melanoma Subtype in Three Trials

February 2nd 2017, 12:47am

Article

Three recent trials showed that Keytruda had a durable response for patients with a rare subtype of melanoma.

Immunotherapy Data is Encouraging in Kidney Cancer

January 26th 2017, 12:37am

Article

Elizabeth Plimack, M.D., discusses an update on the CheckMate-025 trial, comparing Opdivo to Afinitor in patients with metastatic renal cell carcinoma.

Expert Discusses Keytruda's Future in Lung Cancer

January 20th 2017, 12:19am

Article

Roy Herbst, M.D., Ph.D., spoke with CURE about the future of Keytruda, and immunotherapy in general, to treat lung cancer.

Managing Immunotherapy Side Effects in Melanoma: Quick Intervention Is Key

December 14th 2016, 12:24am

Article

Immunotherapy agents have their own set of side effects, and managing them quickly and efficiently is key.

Lights, Camera, Cancer

December 9th 2016, 9:13am

Article

How and why I've chosen to live my cancer in the public eye.

Working at the Speed of Light in Melanoma Advancements

December 8th 2016, 9:29pm

Article

Growing scientific insights have led to the swift development of treatments for advanced melanoma, leaving doctors to iron out details about their application.

Hanging on for Dear Life: The Evolving Role of Immunotherapy and Targeted Therapy for Lung Cancer

December 8th 2016, 8:47pm

Article

The role of immunotherapies and targeted treatments in lung cancer is evolving at breakneck speed.

Immunotherapy Agent Improved Quality of Life in Lung Cancer Study

December 8th 2016, 7:56pm

Article

Keytruda improved quality of life for patients with lung cancer in a recent trial.

What's Next in Immunotherapy?

December 3rd 2016, 2:19am

Video

Melanoma should not be considered to be in a "special category" that responds well to immunotherapy, according to Christian M. Capitini, M.D., assistant professor of Pediatrics at the University of Wisconsin.